Ground-breaking Collaboration pursues the early detection of Endometrial and Ovarian Cancers
Mirage News: New York City-based Icahn School of Medicine at Mount Sinai and Adelaide, South Australia-based Numedico Technologies, have signed a Collaboration Development Agreement (CDA). The international collaboration team will design, develop and commercialise a device for the screening and early detection of …
Mount Sinai Health System Top 10 Researchers
It’s our pleasure to introduce the Top 10 Mount Sinai researchers who have shared their discoveries with MSIP in the form of a Technology Disclosure, a written description of the inventor(s) technology. Disclosures allow MSIP to survey the landscape of translational discoveries …
ShangPharma Innovation And Icahn School Of Medicine At Mount Sinai Forge Translational Research Collaboration
Medical Health News ShangPharma Innovation Inc., a global venture capital firm focused on biomedical R&D therapeutics and technologies, and the Icahn School of Medicine at Mount Sinai has entered into a multi-year strategic collaboration to accelerate the development of novel early-stage therapeutics. …
Compugen to Enter Research Collaboration with Mount Sinai on Novel Myeloid Immuno-Oncology Targets
Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced the initiation of a multi-year cancer immunotherapy research collaboration with Mount Sinai, under the direction of Miriam Merad, MD, PhD, Director of the …
InDevR Licenses Mount Sinai Influenza Antibodies for VaxArray® Neuraminidase Potency Assay
InDevR, a Boulder-based progressive analytical technology and life science instrumentation company today announced that it has entered into an exclusive, world-wide license agreement for monoclonal antibodies developed by scientists at the Icahn School of Medicine at Mount Sinai. The license agreement with Mount …
Mount Sinai Health System Partners With Contessa Health to Expand Hospital-Level Care at Home Program
The Mount Sinai Health System announced today that it has partnered with Contessa Health, an innovative health care company that manages acute-care services at home through prospective bundled payment arrangements, to extend Mount Sinai’s existing hospital-level care at home program, known as …
Technology from a Mount Sinai Startup (Cardea Sciences) That Will Improve Outcomes for Cardiac Patients Wins the NYC Life Science Innovation Showcase
July 18, 2017 – Technology for identifying at-risk atrial fibrillation (AFib) patients was chosen as the winner of the inaugural Alexandria LaunchLabs Scholarship Award, which recognizes excellence in health care technology, entrepreneurship and business competencies. The technology, developed by a Mount Sinai …
Breathing in a New Gene Therapy to Treat Pulmonary Hypertension
June 12, 2017- Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure. If …